Supplementary Table 1 from Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 36K, Supplementary Table 1: Protein regulation after Bevacizumab monotherapy.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361882452